Operating at the intersection of science, technology and business strategy, Health Advances provides clients with innovative solutions based on deep industry insight, analytical rigor and an objective perspective.

Autoimmune Diseases Cardio and Peripheral Vascular Diseases CNS Diseases Dermatology and Wound Care Diabetes, Obesity, and Endocrine Diseases Genitourinary Diseases Infectious Diseases Oncology and Hematology Ophthalmology and Otolaryngology Orthopedics Respiratory Conditions Women's Health Other Clinical Areas Select Clinical Trial Strategy Due Diligence Launch Strategy and Salesforce Market Assessment and Forecasting Partnering and Licensing Portfolio Planning Reimbursement and Pricing Strategy Product Positioning Strategic and Business Planning Technology Commercialization Valuation and Financial Analysis Select Biotechnology Diagnostics Drug Delivery Life Sciences Medical Devices Not-for-Profit Organizations Personalized Medicine Pharmaceuticals Private Equity Venture-Backed Companies Select Health Advances’ expanding practice is constantly in search of highly motivated individuals with exceptional skills and a passion for healthcare. learn more   EPEMED Conference Kristin Pothier, Partner, delivered a presentation at the European Personalized Medicine Association (EPEMED) Conference in Luxembourg titled, "Economics of Life Science Innovation and Personalized Medicine," highlighting the business strategy, financial investment and costs associated with the global expansion of Life Science and Personalized Medicine. learn more. learn more about our expertise in personalized medicine. Next Generation Combination Therapy in Oncology Contributing Authors Aidan Finley, Consultant and Vivek Mittal, PhD, Manager, share their perspectives on how cancer drug development can evolve from a focus on single agents to better embrace targeted combinations in the November 2011 edition of In Vivo. Along with this article, Aidan has authored a summary post on Elsevier's In Vivo Blog. learn more. read the article (PDF498KB). read Aidan's post on the In Vivo Blog. learn more about our expertise in oncology. Partnering for Cures 2011 Marie Schiller, Partner, served as an Expert Consultant at Partnering for Cures 2011. The meeting was an opportunity to find nontraditional allies who can help companies advance their medical research goals, and a platform for solutions needed to accelerate progress. learn more. learn more about our expertise in strategic and business planning. Genetic Test Offerings to the American Population Kristin Pothier, Partner, joined Troyen Brennan, MD, MPH, Executive VP & CMO of CVS Caremark; Louis Hochheiser, MD, VP & Chief Medical Leader of Humana Inc.; Glen Stettin, MD, CMO of Medco; and, Matthew Zubiller, VP, Decision Management at McKesson Health Solutions in a panel discussion: "Genetic Test Offerings to the American Population" at the Personalized Medicine Conference at Harvard Medical School in Boston. learn more. listen to a podcast related to this event. Health Advances All Rights Reserved.     Privacy    Terms of Use find us on facebook